Copyright
©The Author(s) 2015.
World J Gastroenterol. May 21, 2015; 21(19): 6018-6025
Published online May 21, 2015. doi: 10.3748/wjg.v21.i19.6018
Published online May 21, 2015. doi: 10.3748/wjg.v21.i19.6018
Figure 2 Serum tryptase (A) and trans-arterial chemoembolization (B) levels before TACE.
A: Shows a strong correlation between serum tryptase levels before trans-arterial chemoembolization (TACE) and serum tryptase levels after TACE, in that a decreased tryptase levels is always present for each patient; B: Shows a good correlation between serum VEGF levels before TACE and serum VEGF levels after TACE, in that an increased VEGF levels is always present for each patient.
- Citation: Ranieri G, Ammendola M, Marech I, Laterza A, Abbate I, Oakley C, Vacca A, Sacco R, Gadaleta CD. Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patients. World J Gastroenterol 2015; 21(19): 6018-6025
- URL: https://www.wjgnet.com/1007-9327/full/v21/i19/6018.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i19.6018